Drug Compound Leads To Death Of Ovarian Cancer Cells Resistant T...

Courtesy ScienceDaily Mon, 04/21/2008 - 10:00

In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.

More related items

Protein Compels Ovarian Cancer Cells To Cannibalize...
A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers report in Cancer Research.

New Platinum-phosphate Compounds Kill Ovarian Cancer...
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new...

New platinum-phosphate compounds kill ovarian cancer...
(Ohio University) A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs,...

Backyard Livestock: Raising Good, Natural Food for...
This popular and widely praised book describes everything you need to know about selecting and raising small livestock.Long the primary reference for anyone who keeps animals as a sustainable...

The Complete Guide to Asperger's Syndrome
"The Complete Guide to Asperger's Syndrome" is the definitive handbook for anyone affected by Asperger's syndrome (AS). It brings together a wealth of information on all aspects of the...